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Abstract
Microsurgical resection of primary brain tumors located within or near eloquent areas is challenging. Primary aim is to preserve
neurological function, while maximizing the extent of resection (EOR), to optimize long-term neurooncological outcomes and
quality of life. Here, we review the combined integration of awake craniotomy and intraoperativeMRI (IoMRI) for primary brain
tumors, due to their multiple challenges. A systematic review of the literature was performed, in accordance with the Prisma
guidelines. Were included 13 series and a total number of 527 patients, who underwent 541 surgeries. We paid particular
attention to operative time, rate of intraoperative seizures, rate of initial complete resection at the time of first IoMRI, the final
complete gross total resection (GTR, complete radiological resection rates), and the immediate and definitive postoperative
neurological complications. The mean duration of surgery was 6.3 h (median 7.05, range 3.8–7.9). The intraoperative seizure
rate was 3.7% (range 1.4–6; I^2 = 0%, P heterogeneity = 0.569, standard error = 0.012, p = 0.002). The intraoperative complete
resection rate at the time of first IoMRI was 35.2% (range 25.7–44.7; I^2 = 66.73%, P heterogeneity = 0.004, standard error =
0.048, p < 0.001). The rate of patients who underwent supplementary resection after one or several IoMRI was 46% (range 39.8–
52.2; I^2 = 8.49%, P heterogeneity = 0.364, standard error = 0.032, p < 0.001). The GTR rate at discharge was 56.3% (range
47.5–65.1; I^2 = 60.19%, P heterogeneity = 0.01, standard error = 0.045, p < 0.001). The rate of immediate postoperative
complications was 27.4% (range 15.2–39.6; I^2 = 92.62%, P heterogeneity < 0.001, standard error = 0.062, p < 0.001). The rate
of permanent postoperative complications was 4.1% (range 1.3–6.9; I^2 = 38.52%, P heterogeneity = 0.123, standard error =
0.014, p = 0.004). Combined use of awake craniotomy and IoMRI can help in maximizing brain tumor resection in selected
patients. The technical obstacles to doing so are not severe and can be managed by experienced neurosurgery and anesthesiology
teams. The benefits of bringing these technologies to bear on patients with brain tumors in or near language areas are obvious.
The lack of equipoise on this topic by experienced practitioners will make it difficult to do a prospective, randomized, clinical
trial. In the opinion of the authors, such a trial would be unnecessary and would deprive some patients of the benefits of the best
available methods for their tumor resections.
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Surgical treatment of primary brain tumors located within or
near eloquent areas is challenging. The primary goal is to
preserve neurological function, while maximizing the extent
of resection to optimize long-term neurooncological outcomes
and thus quality of life.
In fact, it has been previously acknowledged that in prima-
ry brain tumors, the extent of resection (EOR) is associated
with overall survival (OS) [3, 20, 44]. Moreover, increase in
EOR reduces the incidence of tumor recurrence and further of
malignant transformation in low-grade gliomas (LGG) [1, 27].
However, lesions in eloquent areas pose a particular chal-
lenge. Moreover, surgical resection is just a part of the multi-
modal management of patients with these lesions.
Reports of the use of intraoperative magnetic resonance
imaging (IoMRI) have been conflicting with regard to an in-
crease of the EOR [6, 16]. Intraoperative images were initially
considered to lead to a 20% increase in the volume of total
tumor resection [33, 48], especially for low-grade gliomas
(LGG). However, in more recent series, this benefit might
be considered much higher. The “flip side” benefit is in com-
plication avoidance as a result of images that confirm that
surgical goals have been reached. This is of particular impor-
tance for “eloquent” brain areas the injury to which can cause
neurological deficits that will notably affect quality of life
(QoL). The two surgical goals remain maximal EOR, while
preserving neurological function [43].
The use of intraoperative electrical stimulation has become
an accepted standard for defining cortical areas underlying
eloquent function [2, 8, 34]. Use of this method has been
shown to improve functional outcomes for surgical resection
in close proximity to eloquent areas of cortical function [55].
Awake craniotomy has a long neurosurgical track record
and is usually recommended for patients who need removal of
lesions from the areas of eloquent brain where language func-
tion would be at risk, and in surgery for medically refractory
epilepsy. The current goal of such surgery is to preserve neu-
rological functions including motor, language, and cognitive,
for patients with any type of lesions observed near or within
eloquent areas of the brain [30].
Here, we sought to review the combined use and integration
of the operative techniques of awake craniotomy and IoMRI
[23]. Both posemultiple challenges and concerns with regard to
multiple aspects, including patient selection, airway control
during surgery, operative setup, physical constraints, prolonged
operative time, costs, patient comfort, and safety issues.
Methodology
A PubMed search was performed for entries between January
1990 and February 2020 using the following query guidelines:
((awake AND (intraoperative OR intraoperative MRI,
IoMRI)) AND (glioma)). We selected 1990 as a starting date
to be sure we did not miss any relevant reference. Inclusion
criteria required that each article be a peer-reviewed clinical
study or case series of primary brain tumors treated with mi-
crosurgical resection, using both the IoMRI and the awake
setting. As such, case reports, non-English studies, and
conference papers or abstracts were not included.
Exclusion criteria included studies reporting non-
tumoral cases. The article selection is illustrated in
Fig. 1, which included the studies reported further in
Tables 1, 2, 3, and 4. Two separate reviewers applied
the inclusion criteria to the PubMed search result; there
were no disagreements. Moreover, four separate re-
viewers applied the exclusion criteria to the remaining
articles. Were included 13 series and a total number of
527 patients, who underwent 541 surgeries.
This study was performed in accordance with the published
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [29].
We paid particular attention to operative time, rate of intra-
operative seizures, rate of initial complete resection at the time
of first IoMRI, the final complete resection rates at the time of
last IoMRI, and the immediate and definitive postoperative
neurological complications.
Statistical analysis using OpenMeta (Analyst) and
random-effects model
Due to the high variation in study characteristics, a sta-
tistical analysis using a binary random-effects model
(DerSimonian-Laird method) was performed. We used
OpenMeta (Analyst) from the Agency for Healthcare
Research and Quality.
Weighted summary rates were determined using meta-
analytical models. Testing for heterogeneity was performed
for each meta-analysis.
Pooled estimates using meta-analytical techniques were
obtained for all the outcomes previously described in the same
section.
Case reports [36] or series not reporting the outcomes for
all included patients were excluded [38].
Results
Number of studies and number of patients
Were included 13 series, encompassing a total number of 527
patients, who underwent 541 surgeries. All studies were ret-
rospective cohort analysis.
The number of included patients ranged from 10 to 106.
Most commonly used MRI fields were 1.5 and 3 Tesla.
Neurosurg Rev
Duration of surgery
The exact duration of surgery can be found in Table 1 and in
Fig. 2. The mean duration of surgery was 6.3 hours (median
7.05, range 3.8-7.9). This has been reported on 6 studies,
including 144 patients[22, 26, 30, 54, 56, 58].
Intraoperative seizure rate
The intraoperative seizure rate was 3.7% (range 1.4–6; I^2 =
0%, P heterogeneity = 0.569, standard error = 0.012, p =
0.002). This has been reported in 4 studies, including 242
patients [12, 26, 31, 59]
Complete resection at the time of first IoMRI
The intraoperative GTR rate at the time of first IoMRI was
35.2% (range 25.7–44.7; I^2 = 66.73%, P heterogeneity =
0.004, standard error = 0.048, p< 0.001). This has been report-
ed in 10 studies, including 303 patients (Fig. 3) [5, 12, 24, 26,
31, 54, 56, 59, 61].
Patients who underwent complementary resection
after IoMRI
The rate of patients who underwent supplementary resection
after one or several IoMRI was 46% (range 39.8–52.2; I^2 =
8.49%, P heterogeneity = 0.364, standard error = 0.032, p <
0.001). This has been reported in 8 studies, including 255
patients [12, 22, 24, 26, 30, 56, 58, 59].
Moreover, the increment of complete resection after IoMRI
was clearly reported in few studies [24, 26, 61].
Gross total resection rates at discharge
The complete resection rate at discharge was 56.3% (range
47.5–65.1; I^2 = 60.19%, P heterogeneity = 0.01, standard
error = 0.045, p < 0.001).
Immediate neurological complications
The rate of immediate postoperative complications was 27.4%
(range 15.2–39.6; I^2 = 92.62%, P heterogeneity < 0.001,
standard error = 0.062, p < 0.001). This has been reported in
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Fig. 1 PRISMA flowchart
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11 studies, including 410 patients (Fig. 4) [12, 22, 24, 26, 30,
31, 54, 56, 58, 59, 61].
Permanent neurological complications
The rate of permanent postoperative complications was 4.1%
(range 1.3–6.9; I^2 = 38.52%, P heterogeneity = 0.123, stan-
dard error = 0.014, p = 0.004). This has been reported in 8
studies, including 324 patients [12, 22, 24, 26, 30, 54, 59, 61]
Discussion
Overall outcomes
In the present meta-analysis, we review the published litera-
ture on the use of awake microsurgical resection combined
with intraoperative MRI. The mean intraoperative seizure rate
was 3.7%. The mean initial (at the time of first IoMRI) and
final (at the time of discharge) GT resection rates were 35.2%
and 56.3%, respectively, including 46% of patients who had
additional resection performed after intraoperative images
showed residual tumor that could be safely resected.
The mean rate of immediate and permanent postoperative
complications was 27.4% and 4.1%, respectively. Several as-
pects warrant for further interest and are detailed below.
Intraoperative MRI for glioma surgery and its benefits
in general
It has been previously acknowledged that IoMRI in-
creases the extent of resection and thus the overall
survival in high-grade gliomas [49]. Moreover, for pa-
tients with low-grade gliomas, the use of IoMRI showed
higher resection rates [15]. In this context, a recent and
large multicentric trial showed that GT resection was an
independent positive prognostic factor for PFS in low-
grade gliomas and confirmed that IoMRI was signifi-
cantly associated with GT resection [5]. In sum, intra-
operative MRI data can be used to localize tumor rem-
nants reliably and can also compensate for the effects of
brain shift [32].
Intraoperative MRI and mapping
Currently, the cornerstone of treatment for low- and
high-grade gl iomas is maximal safe resect ion.
Structural information related to tumor architecture as
depicted by MRI studies should be completed, whenever
necessary, with mapping modalities, determining the re-
lationship of the tumor itself with the eloquent cortex
and subcortical areas to avoid. The success of microsur-
gical resection for brain lesions close to eloquent cortex
is linked to preservation and/or improvement of neuro-
logical functions and, thus, of the quality of life [11].
Integrating anatomical and functional data into the
neuronavigation has nowadays become a standard of
care in many departments dealing with neurooncology
[25]. Moreover, advancement in neuroimaging and neu-
rophysiological techniques and the appearance of the
IoMRI have created a major paradigm shift and in-
creased the EOR.
The main utility of the IoMRI is related to the compensa-
tion of brain shift and in intraoperative control of the















Nabavi et al. (2008) 34, 38 1.5 32:6 - - 3/38 (7.9%)
Weingarten et al. (2009) 10, 10 25–57 1.5 - 6.8 h (3.8–8.7) -
Leuthardt et al. (2011) 12 32–60 1.5 9:3 7.9 (5.9–9.7) 45 (28.8–69)
Lu et al. (2012) 30 45.5 (19–67) 3 - - -
Tuominen et al. (2013) 20 44 (16–67) 0.23 - 4.45 (3.20–7.55) -
Maldaun et al. (2014) 41, 42 41.2 (22–70) 1.5 31:11 7.3 (4–13.9) 15.6 (5.1–27.1) 3/42 (7%)
Coburger et al. (2015) 26 - - - - - -




Zhuang et al. (2016) 20 45 (27–67) 3
Mehdorn et al. (2017) 106 - - - - - -
Motomura et al. (2017) 25, 33 41 (28–67) 0.4 30:3 7.8 (4.4–12)
White et al. (2018) 36 0.15 3.8 (2–6) 15
Whiting et al. (2020) 61, 62 44.5 (19–78) 44:17 2/63 (3.2%)
*13 series including a total of 527 patients, who underwent 541 surgeries, h hours, IoMRI intraoperative MRI
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Table 2 Function mapped, anatomical location, exact histology
Series Function mapped Anatomical location Exact histology
Nabavi et al. (2008) - • L frontal operculum
• L SMA
• Dorsal temporal lobe
-
Weingarten et al. (2009) • Language (n=5)
• Motor (n=7)
• Sensory (n=6)
• L temporal lobe (n=4)
• Posterior L frontal (n=1)
• Posterior R frontal (n=1)
• L parietal (n=1)
• R parietal (n=1)
-
Leuthardt et al. (2011) • Language (n=3)
• Motor (n=1)
• Both (n=8)






• Anaplastic astrocytoma 1/12
• Anaplastic oligoastrocytoma 3/12
• Anaplastic oligodendroglioma 1/12
• Glioblastoma 3/12






• Diffuse astrocytoma 13/30
• Anaplastic oligodendroglioma 1/30
• Glioblastoma 10/30
Tuominen et al. (2013) - • Frontal (n=6)
• Parietal (n=3)
• Temporal (n=4)
• More than one lobe (n=7)
• DNET 1/20
• Oligodendroglioma II (4/20), III (3/20)
• Astrocytoma II (2/20), III (3/20)
• Glioblastoma (4/20)
Maldaun et al. (2014) • Language (n=9)





• More than one lobe (n=9)
• Insular (n=7)
• II and III (n=14)
• IV (n=28)
Coburger et al. (2015) • Language (n=26) - -






• Diffuse astrocytoma 13/30
• Anaplastic oligodendroglioma 1/30
• Glioblastoma 10/30
Mehdorn et al. (2017) - - • Astrocytoma II 10/106
• Astrocytoma III 22/106
• Oligoastrocytoma 3/106
• Oligodendroglioma II 4/106
• Oligoastrocytoma III 5/106
• Anaplastic oligodendroglioma 6/106
• Glioblastoma 46/106
• Recurrent glioblastoma 6/106
• Gliosarcoma 2/106





• Astrocytoma II 9/33
• Oligodendroglioma II 2/33
• Oligoastrocytoma 7/33
• Anaplastic astrocytoma III 2/33
• Anaplastic oligodendroglioma 5/33
• Glioblastoma 4/33
• Pleomorphic xantoastrocytoma 1/33
• Gliosis 3/33




• Mesial temporal sclerosis (1/36)
• Cysticercosis (2/36)
Whiting et al. (2020) • Speech alone 23/62 (37.1%)
• Motor alone 24/62 (38.7%)




• Frontal, extending adjacent lobes (n=6)






microsurgical resection. Other imaging modalities can be fur-
ther added, including functional MRI or diffusion tensor im-
aging, with the illustration of relevant tracts. The former is,
however, limited by the radiological aspect of the intraopera-
tive field, state of resection, etc. Combining IOM and IoMRI
provides functional and structural information, which is ex-
tremely useful for the neurosurgeon, enabling higher resection
rates, while preserving quality of life.
Awake surgery contraindications
Awake surgery cannot be done in patients with pronounced
aphasia, those who have minimal enough residual motor func-
tion, a score under 23 on theMini Mental Status Examination,
and those with apathic/disorganized behavior [31]. Other au-
thors included also large body mass index and potentially
difficult airway as reasons to rule out awake surgery [22].











Complete resection (details) EOR (before and
after IoMRI)
Mean, range
Nabavi et al. (2008) - - - - Yes -
Weingarten et al.
(2009)
- 1/10 (10%) 2/9 (22.2%) 7/9 (77.8%) 7/10 (70%) complete
3/10 (30%) to an eloquent
margin
Leuthardt et al. (2011) - 7/12 (58.3%) 5/12 (41.7%) 6/12 (50%) 5/12 (41.7%) complete
2/12 (16.7%) nearly total
5/12 (41.7%) subtotal
-
Lu et al. (2012) 60
(8.4–216.7)
11/30 (36.7%) 19/30 (63.3%) 11/30 (36.7%) 18/30 (60%) complete
(grace to IoMRI 7/18 (60%))
92.5% (75.1–97)
100% (92.6–100)
Tuominen et al. (2013) - - - 10/20 (50%) complete -
Maldaun et al. (2014) 49
(3.3.–154.2)
- 25/42 (59.5%) 17/42 (40.5%) 17/42 gross total (40.5%)
(grace to IoMRI 7/17 (41%))
56%
67%
Coburger et al. (2015) - - - 17/26 (65.4%) -
Ghinda et al. (2016) 58
(3.5–181.3)
44/106 (41.5%) 32/62 (51.6%) 30/62 (48.4%) 64/106 (60.4%) -
Zhuang et al. (2016) - 16/30 (53%)
GTR
- - 23/30 (77%) 53%
77%
Mehdorn et al. (2017) - - - - - -
Motomura et al. (2017) 46.1
(0.6–196.4)
9/25 (36%) 9/16 (56.2%) 7/16 (43.8%) - -
White et al. (2018) - 12/36 (33%) 16/24 (66.7%) 18/36 (50%) - -
Whiting et al. (2020) - 14/62 (22.6%) 7/48 (14.6%) 41/48 (85.4%) 27/63 (42.8%) -
Table 4 Postoperative






Nabavi et al. (2008) 0/38 (0%) - -
Weingarten et al. (2009) 3/10 (30%) - -
Leuthardt et al. (2011) 5/12 (41.7%) 1/12 (8.3%) 11/12 (91.7%)
Lu et al. (2012) 12/30 (40%) 1/30 (3.3%) -
Tuominen et al. (2013) 2/20 (10%) 1/20 (5%) 16/20 (80%)
Maldaun et al. (2014) 11/42 (26.2%) 1/42 (2.3%) -
Coburger et al. (2015) - - -
Ghinda et al. (2016) 48/106 (46.2%) 9/106 (8.7%) -
Zhuang et al. (2016) 10/20 (50%) 1/18 (5.6%) -
Mehdorn et al. (2017) - - -
Motomura et al. (2017) 17/33 (51.5%) 4/33 (12%) -
White et al. (2018) 3/36 (8.3%) - -
Whiting et al. (2020) 8/63 (12.7%) 0/63 (0%) -
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The major role of the anesthesiology team
The role of the anesthesiologist is crucial both preoperatively,
to determine if the patient is a suitable candidate (both at
medical and emotional levels, in terms of complete comfort
during the procedure), and intraoperatively (patient able to
talk and to follow commands [4]).
Patient position
The patient should be positioned in a way that she/he could
have a large visual field view, including of the neuropsychol-
ogist’s team. Moreover, the patient should be able to visualize
any images or numbers seen on the computer and further
needing to be described.
The patient installation could also benefit from a transpar-
ent sterile field towards the neuropsychologists and anesthesi-
ologists side, so as to facilitate the contact with both teams.
The most common, the “AAA” technique
The most common procedure is a combination of general
anesthesia and an awake technique, in what is known as the
“asleep awake asleep” (AAA) technique. By this approach,
the patient is placed under general anesthesia (without intuba-
tion) before and after brain tumor resection in awake. Usually,
there is an initial phase of general anesthesia, followed by
intraoperative awakening, and finally back to general anesthe-
sia for the end of the surgery [40]. However, not all studies
specifically detailed their awake technique. An important ad-
junct can be, in selected cases, intraoperative hypnosis [60].
Intraoperative focal seizures
Cortical stimulation can provoke a seizure, the incidence of
which is estimated to be between 5 and 20% [47]. These
episodes usually can be managed by cold Ringer’s lactate
solution irrigation of the cortex and patience, without the need
for intravenous antiepileptic medication [46]. Postictal paresis
might further limit the progress of surgery. Moreover, repeat-
ed seizuresmight lead to a long postictal period that can render
the continuation of surgery difficult if not impossible. Of note,
potential brain swelling can further complicate continuing the
surgery. Hence, the interest of starting to progressively stim-
ulate from lower to higher intensity.
Cortical mapping
Penfield and Boldrey [37] first mapped the motor and sensory
homunculi by stimulating the cerebral cortex with a
monopolar electrode in conscious patients undergoing brain
surgery for epilepsy. Bipolar ESM was later used during tu-
mor surgery and for language area localization [57]. More
recently, ESM has further been used to identify critical sub-
cortical white matter tracts [10]. Motor mapping can be per-
formed in patients under general anesthesia, with various re-
sults [42]. Of note, stronger cortical stimulation can favor ictal
events; hence, the interest to couple it with EMG. However,
speech mapping must be performed awake. Motor and speech
testing are rehearsed before surgery. The most complex re-
mains speech monitoring, ranging from naming to association
and free narration. For speech localization during awake sur-
gery, object naming is preferred to number counting. The
Fig. 2 The mean, minimal, and
maximal operative times (in
hours)
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heterogeneity of cortical areas activated during speech forma-
tion makes the cortical mapping of these areas in practice










Fig. 4 Neurological complications. (A) Intraoperative partial seizures. (B) Immediate postoperative complications. (C) Permanent postoperative
complications
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Cortical mapping is thus a method that delinates
functional areas during brain tumor surgery and
preventing inadvertent injury to eloquent cortical and
subcortical structures [57]. Many groups use the
Ojemann bipolar cortical stimulator (Integra Inc). This
probe has a 5-mm spacing between the electrodes. It
relies on a constant current generator that produces a
train of square-wave biphasic pulses. The most common
settings include a 1 msec phase duration at a frequency
of 60 Hz. For localization of primary language and mo-
tor cortices, stimulus is applied in increments starting at
1 mA. The Rolandic cortex may also be identified by
somatosensory evoked potentials, to identify phase re-
versal and latency shift. No cortical site is stimulated
twice in succession. Usually 2–3 mA is the maximum
stimulus needed to localize the language center in an
awake patient. In an asleep case, 10 mA may be needed
to localize the motor cortex. If used correctly, a meta-
analysis showed less than 4% rate of permanent severe
neurological deficits in patients after resection with in-
traoperat ive st imulation mapping [7]. Of note,
monopolar probe can be also safely used in an IoMRI
setting both for navigation and stimulation purposes
during the resection of primary brain tumors under gen-
eral anesthesia [41]. Additionally, subcortical MEP map-
ping can be of further help to evaluate the distance
towards the corticospinal tract during resection of
motor-eloquent lesions thus reducing the risk of neuro-
logical deficit [50]. Combining information about intra-
operative corticospinal tract together with direct electri-
cal stimulation in the setting of IoMRI can enhance
resection of brain tumors, with up to 77% having a
GTR, as suggested by some authors [18].
Language tasks of specific interest
Three language tasks should be performed: counting
from 1 to a specific number (e.g., 50), picture naming,
and word reading. One should also distinguish language
deficits (speech arrest, anomia, or alexia) from dysar-
thria, which is caused by involuntary muscle (mouth
or pharyngeal) contraction.
To localize language areas, fMRI and brain mapping using
DCS have been commonly applied. Although fMRI is a non-
invasive test, it has limited spatial resolution, with various
sensitivity and specificity [13, 51]. The fMRI language acti-
vations do not necessarily correlate with intraoperative corti-
cal stimulation findings. Moreover, because of the complexity
of language area representation, fMRI has limited ability com-
pared with cortical mapping for identification of such area; in
fact, fMRI can be used for identifying language lateralization
(left or right hemisphere), but less for precisely pointing out
the cortical areas involved in language [53]. Therefore, DCS
has been shown to be a reliable predictor of functional recov-
ery [9, 45]
Cortical resection
Cortical resection has to be performed at least 1–2 cm from
areas of motor, sensory, or essential language function as
identified by ESM [56]. However, more conservative recom-
mendations suggest resection margins within 1–2 cm for
speech function, and up to 0.5 cm for sensory and motor
cortices. However, such conservative recommendation might
preclude a maximal EOR. The neuropsychologist monitors
the motor and speech function throughout the procedure.
The authors increased the frequency of checks when the sur-
geons approached an identified area of eloquence. A resection,
which is stopped if speech function deteriorates, can be re-
sumed if clinical resolution resumes within 5 min.
Extent of resection
In some of the series, there was no statistically significant
difference in terms of EOR between low-grade and high-
grade gliomas [26], while in others GTR was significantly
lower in LGG as compared with HGG [12]. The usual strategy
is to perform a staged volume surgery (with >= 1 IoMRI),
while leaving in place a strategic tumor remnant, to avoid
problems related to brain shift and further update
neuronavigation [21] with IoMRI.
Supramaximal resection and transient deficit
Some authors advocate performing a supramaximal resection
despite the likelihood of a neurological deficit that hopefully
will prove transient, because tissue plasticity and reorganiza-
tion can further allow subsequent recovery [12]. In some of
the studies, this was translated into a survival benefit [12].
However, the molecular biology of the tumors should be more
taken into account in such type of studies
Learning curve
Some of the authors stressed that there was a learning curve in
applying these technologies [12]. This is considered related to
the fact that surgeons often perform a less aggressive approach
to decrease the rate of postoperative neurological deficits,
which might result in a suboptimal tumor resection.
Lau et al. [19] further suggested that there is a learning
curve associated with the ability to accurately assess intraop-
erative EOR during glioma surgery, and it may take more than
a decade to become truly proficient. Moreover, the authors
suggested that understanding the factors associated with the
ability to accurately assess EOR will provide safer surgeries
while maximizing tumor resection.
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Pitfalls and other adjuvant complementary
approaches
Awake surgery with IoMRI takes longer. Thus, patients must
be cooperative and motivated to participate with awake lan-
guage mapping. Further refinement of the awake technique
could be the patient’s sedation with Propofol. This has been
reported by several centers [17, 35] reporting no adverse ef-
fects on the cortical stimulation after discontinuation of
Propofol. Intraoperative fluorescence-guided resection has
been shown to enhance the EOR [52]. One might consider
that longer procedures might add to the risk of infection, deep
venous thrombosis, and pulmonary embolism [56]. However,
the complication rate did not increase [14].
A major aspect is the higher load of surgical information,
which is demanding for the surgeons in terms of integration.
Sedation
Some of the authors [56] reported craniotomy being per-
formed with local anesthesia and intravenous sedation; more-
over, intravenous sedation was withdrawn after performing
the craniotomy but before opening the dura mater. Other cen-
te r s cons ide red mode ra te in t ravenous seda t ion
(Dexmedetomidine) and generous local anesthesia
(bupivacaine) before patient positioning. Lu et al. [24] pro-
posed moderate sedation with boluses of intravenous
Propofol, while Tuominen et al. [54] used fentanyl and
propofol (and further suspended sedation during cortical stim-
ulation). In the series of Ghinda et al. [12], boluses of porpofol
were used, followed by continuous administration of a low




The combine setting of IoMRI and awake microsurgical re-
section is particularly useful for patients with tumors localized
in functional areas. The complete postoperative resection rates
might seem lower as classically reported for non-functional
locations and the use of IoMRI. One useful strategy is to
initially start resection after identifying the eloquent areas by
cortical stimulation to optimize resection close to the area.
IoMRI would become then useful to evaluate what one has
left as residual tumor distant from such areas, to reassess
neuronavigation data and optimize resection of this remnant.
Comparative studies
A first comparative study was performed by Tuominen et al.
[54], who compared patients having surgery with IoMRI and
awake craniotomy to a group operated under general
anesthesia and without cortical stimulation, while keeping
the IoMRI setting. The authors concluded that awake craniot-
omy with bipolar cortical stimulation may help to reduce the
risk of postoperative impairment following resection of tu-
mors located in or near speech and motor areas.
A second comparative study by Mehdorn et al. [28] evalu-
ated patients treated with two different approaches: awake
craniotomy without (first period) and with (second period)
intraoperative MRI. The authors suggested that there was a
slight preponderance in redo surgeries for tumor remnant in
the first period (11.2%) as compared with the second (7.4%).
Moreover, the intervals between surgeries in both groups
depended mainly on the histological grade. An interesting
aspect was that patients with low-grade gliomas in the second
series did not experience recurrences as frequently as those in
the first series.
Major limitation in the current studies
One of the major limitations, which should be addressed by
further studies, is to correctly report the increment of complete
resections from first to last IoMRI. This would better enhance
the utility of such an approach and provide the reader a correct
information.
A second limitation is related to the awake examination
after IoMRI. Moreover, further studies should report the exact
number of IoMRI assessments, but also whether or not the
patients have been putted into sleep or not during these
single/multiple examinations.
Conclusion
Awake craniotomy with language mapping can be combined
successfully with IoMRI to maximize resection of brain tu-
mors in selected patients and preserving neurological func-
tion. The technical obstacles to doing so are not severe and
can be managed by experienced neurosurgery and anesthesi-
ology teams. The benefits of bringing these technologies to
bear on patients with brain tumors in or near language areas
are obvious. The lack of equipoise on this topic by experi-
enced practitioners will make it difficult to do a prospective,
randomized, clinical trial.
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